EICHORPublic-registry site landscape for NCT04513912, “A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy”, a Depressive Disorder, Major study sponsored by Janssen Research & Development, LLC. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04513912 (registry record) |
| Study title | A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy |
| Official title | Double-Blind, Randomized, Parallel-Group Study With Quetiapine Extended Release as Comparator to Evaluate the Efficacy and Safety of Seltorexant 20 mg as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy |
| Sponsor | Janssen Research & Development, LLC |
| Condition(s) | Depressive Disorder, Major |
| Phase | PHASE3 |
| Listed sites | 175 |
| Site countries | United States, Argentina, Belgium, Bulgaria, Canada, Czechia, Latvia, Lithuania, Malaysia, Poland, Russia, Serbia |
Patient-friendly overview of this study: eichor.com/study/NCT04513912.
Eichor generates a preliminary site-risk snapshot for NCT04513912 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
Other Depressive Disorder, Major trials
More from Janssen Research & Development, LLC
← Eichor home · All tracked trials · Depressive Disorder, Major studies · Weekly briefs
